Related Experiment Video

Updated: May 30, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas

Fernanda Falcini1, Serena Capannini, Donato Rigante

  • 1Department of BioMedicine, Section of Rheumatology, Transition Clinic, University of Florence, Florence, Italy. falcini@unifi.it.

Pediatric Rheumatology Online Journal
|July 22, 2011
PubMed

Insights

Kawasaki disease (KD) remains a mystery, causing coronary artery damage in children and leading to acquired heart disease. Further research is needed to understand its causes, improve treatments, and manage long-term effects.

Area of Science:

  • Pediatric Cardiology
  • Rheumatology
  • Immunology

Background:

  • Kawasaki syndrome (KS) is the leading cause of acquired heart disease in children in developed nations.
  • It affects coronary arteries in a significant portion of untreated patients, leading to potential long-term cardiovascular complications.
  • Despite decades of study, the etiology and pathogenesis of KS remain poorly understood, hindering therapeutic advancements.

Purpose of the Study:

  • To highlight the persistent knowledge gaps in Kawasaki syndrome (KS) understanding.
  • To emphasize the challenges in diagnosing and managing atypical or incomplete KS cases, particularly in infants.
  • To underscore the need for improved long-term follow-up strategies and multidisciplinary care for KS patients.

Main Methods:

  • Review of existing literature on Kawasaki syndrome (KS) epidemiology, clinical presentation, and diagnostic challenges.
  • Discussion of current diagnostic standards, including transthoracic echocardiography and advanced imaging modalities.
  • Analysis of the long-term sequelae and the necessity for collaborative management approaches.

Main Results:

  • Significant gaps persist in understanding KS etiology, pathogenesis, and genetic predisposition.
  • Early diagnosis is hampered by the lack of specific biomarkers for atypical and incomplete KS presentations.
  • Current therapies show unpredictable effectiveness, and long-term risks like premature atherosclerosis require further investigation.

Conclusions:

  • Further research is crucial to elucidate the underlying mechanisms of Kawasaki syndrome (KS).
  • Development of specific diagnostic tests is needed for early identification and timely treatment, especially in infants.
  • Multidisciplinary collaboration and specialized guidelines are essential for managing the long-term cardiovascular health of KS survivors.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...